Correlation Between X4 Pharmaceuticals and Century Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Century Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Century Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Century Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XFOR and Century is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Century Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Century Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Century Therapeutics. In addition to that, X4 Pharmaceuticals is 1.27 times more volatile than Century Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Century Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 300.00 in Century Therapeutics on August 28, 2024 and sell it today you would lose (170.00) from holding Century Therapeutics or give up 56.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Century Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Century Therapeutics |
X4 Pharmaceuticals and Century Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Century Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals |
| Century Therapeutics vs. Eliem Therapeutics | Century Therapeutics vs. HCW Biologics | Century Therapeutics vs. Scpharmaceuticals | Century Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |